Medifast, Inc. (MED) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

First Advantage Corp.

V2X, Inc.

The Andersons, Inc.

OPENLANE, Inc.

PagSeguro Digital Ltd.

Huron Consulting Group, Inc.

Montrose Environmental Group, Inc.

Thoughtworks Holding, Inc.

Medifast, Inc.

Chegg, Inc.

LegalZoom.com, Inc.

Why is Medifast, Inc. ?

With a fall in PBT of -258.16%, the company declared Very Negative results in Jun 25

The company has declared negative results for the last 12 consecutive quarters
NET PROFIT(HY) At USD 0.33 MM has Grown at -87.43%
OPERATING CASH FLOW(Y) Lowest at USD 4.15 MM
NET SALES(Q) Lowest at USD 105.56 MM

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -43.61% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Medifast, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Medifast, Inc.

-24.38%

-1.08

40.40%

S&P 500

20.78%

0.70

20.15%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-16.22%

EBIT Growth (5y)

-163.83%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.75

Sales to Capital Employed (avg)

3.36

Tax Ratio

3.78%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

184.68%

ROE (avg)

54.42%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.54

EV to EBIT

3.91

EV to EBITDA

-55.51

EV to Capital Employed

-1.53

EV to Sales

-0.14

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-9.21%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bollinger Bands

Sideways

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bearish

Mildly Bullish

Dow Theory

Mildly Bullish

Mildly Bearish

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

3What is working for the Company

DEBT-EQUITY RATIO (HY)

Lowest at -77.32 %

OPERATING PROFIT MARGIN(Q)

Highest at 3.14 %

NET PROFIT(Q)

At USD -2.12 MM has Grown at 49.62%

-27What is not working for the Company

NET PROFIT(HY)

At USD -17.04 MM has Grown at -1,604.11%

OPERATING CASH FLOW(Y)

Lowest at USD 3.71 MM

NET SALES(Q)

At USD 76.04 MM has Fallen at -21.15%

ROCE(HY)

Lowest at -9.8%

PRE-TAX PROFIT(Q)

At USD -1.94 MM has Fallen at -37.29%

RAW MATERIAL COST(Y)

Grown by 6.6% (YoY

Here's what is working for Medifast, Inc.

Operating Profit Margin

Highest at 3.14 %

in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Net Profit

At USD -2.12 MM has Grown at 49.62%

over average net sales of the previous four periods of USD -4.21 MM

MOJO Watch

Near term Net Profit trend is positive

Net Profit (USD MM)

Debt-Equity Ratio

Lowest at -77.32 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Here's what is not working for Medifast, Inc.

Net Sales

At USD 76.04 MM has Fallen at -21.15%

over average net sales of the previous four periods of USD 96.45 MM

MOJO Watch

Near term sales trend is extremely negative

Net Sales (USD MM)

Operating Cash Flow

Lowest at USD 3.71 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Pre-Tax Profit

At USD -1.94 MM has Fallen at -37.29%

over average net sales of the previous four periods of USD -1.41 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Raw Material Cost

Grown by 6.6% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales